文献速递角膜与眼表疾病眼底病与葡萄膜炎

眼表IL-1α/IFN-γ通过线粒体功能障碍与NLRP3炎症小体激活延迟类风湿关节炎角膜伤口愈合

Ocular IL-1α/IFN-γ Delay the Corneal Wound Healing in Rheumatoid Arthritis Through Mitochondrial Dysfunction and NLRP3 Inflammasome Activation.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2026-01-01

本研究整合人类临床样本、小鼠胶原诱导性关节炎(CIA)模型及人角膜上皮细胞(HCEC)培养,结合Olink蛋白组学与转录组学分析,探讨类风湿关节炎(RA)相关角膜上皮伤口愈合(CEWH)延迟的机制。RA患者表现为CEWH延迟、泪液分泌减少及眼表炎症加重,伴OSM、IL-1α和IFN-γ升高。IL-1α/IFN-γ通过破坏线粒体完整性并放大NLRP3介导的炎症级联损伤角膜上皮功能,而NLRP3抑制剂MCC950可恢复HCEC功能并加速CIA模型CEWH。

要点

  • RA患者存在CEWH延迟、泪液分泌减少及眼表炎症,伴OSM、IL-1α和IFN-γ升高。
  • IL-1α/IFN-γ共暴露损害OSM对HCEC增殖、迁移及线粒体呼吸的有益效应。
  • MCC950阻断NLRP3可恢复HCEC线粒体功能并加速CIA模型CEWH。

核心结论

  • 眼表IL-1α/IFN-γ通过破坏线粒体完整性并放大NLRP3介导的炎症级联,损害角膜上皮功能,从而参与RA患者CEWH延迟。

研究设计与样本

  • 整合人类临床样本、小鼠CIA模型、HCEC培养平台以及Olink蛋白组学和转录组学分析。
  • 使用NLRP3炎症小体抑制剂MCC950进行干预验证。

主要发现

  • RA患者表现为CEWH延迟、泪液分泌减少和眼表炎症加重,伴OSM、IL-1α和IFN-γ升高。
  • OSM单独促进HCEC增殖和迁移并增强线粒体呼吸能力,但IL-1α和IFN-γ共暴露明显损害这些有益效应。
  • IL-1α/IFN-γ共暴露伴随严重线粒体损伤、氧化磷酸化受损和NLRP3炎症小体活性增加。
  • MCC950阻断NLRP3可显著恢复受IL-1α/IFN-γ损害的HCEC功能,改善线粒体超微结构和功能。
  • 局部给予MCC950加速CIA模型CEWH。

临床怎么用

  • RA患者出现角膜上皮愈合延迟时,应考虑眼表IL-1α/IFN-γ升高及NLRP3炎症小体激活的病理作用。
  • NLRP3炎症小体抑制剂MCC950在实验模型中可恢复HCEC功能并加速CEWH,提示靶向NLRP3可能为RA相关角膜愈合延迟的潜在干预策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Rheumatoid arthritis (RA) is an autoimmune disease often associated with corneal ulceration and impaired corneal epithelial wound healing (CEWH), although the underlying cause remains unclear. This study aims to elucidate the pathogenic mechanism of RA-associated delayed CEWH. METHODS: We integrated analyses of human clinical samples, a murine collagen-induced arthritis (CIA) model, a human corneal epithelial cell (HCEC) culture platform, as well as Olink proteomic and transcriptomic analysis. We characterized RA-related ocular phenotypes, evaluated the effects of IL-1α/IFN-γ on HCECs, and validated interventions using the NLRP3 inflammasome inhibitor MCC950. RESULTS: RA patients exhibited delayed CEWH, reduced tear secretion, and heightened ocular surface inflammation characterized by elevated Oncostatin M (OSM), IL-1α and IFN-γ. OSM alone promoted the proliferation and migration of HCECs and enhanced mitochondrial respiratory capacity. However, these beneficial effects were markedly impaired when OSM-treated HCECs were co-exposed to IL-1α and IFN-γ, an effect accompanied by severe mitochondrial damage, compromised oxidative phosphorylation, and increased NLRP3 inflammasome activity. Notably, pharmacological blockade of NLRP3 inflammasome with MCC950 significantly restored HCEC functions compromised by IL-1α/IFN-γ exposure, with improved mitochondrial ultrastructure and function. Furthermore, topical MCC950 administration accelerated CEWH in the CIA model. CONCLUSIONS: Ocular IL-1α/IFN-γ impairs corneal epithelial function by disrupting mitochondrial integrity and amplifying NLRP3-mediated inflammatory cascades, thereby contributing to delayed CEWH in RA patients.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Ren Z, Cao D, Meng J, et al. Ocular IL-1α/IFN-γ Delay the Corneal Wound Healing in Rheumatoid Arthritis Through Mitochondrial Dysfunction and NLRP3 Inflammasome Activation. Invest Ophthalmol Vis Sci. 2026. PMID: 42417589. doi:10.1167/iovs.67.8.27

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。